Securities code: Tianjin Songjiang Co.Ltd(600225) securities abbreviation: Tianjin Songjiang Co.Ltd(600225) Announcement No.: pro 2022028 Tianjin Songjiang Co.Ltd(600225)
Announcement of resolutions of the 15th meeting of the 10th board of supervisors
The board of supervisors shall not be jointly and severally liable for any misrepresentation, omission or material misrepresentation of the contents of this announcement, and shall not guarantee the authenticity and completeness of the contents of this announcement.
Tianjin Songjiang Co.Ltd(600225) (hereinafter referred to as “the company”) the 15th meeting of the 10th board of supervisors (hereinafter referred to as “the meeting”) was held at 11:30 on April 25, 2022 in the conference room of the company, No. 1 Xiangtan Road, Hongqiao District, Tianjin.
The meeting was held by means of on-site combined with communication voting. There were 5 supervisors who should attend the meeting and 5 supervisors who actually attended the meeting (including Mr. Zhang Yunbing, chairman of the board of supervisors, Mr. Xing Zhiguo, supervisor and Mr. Tang Wei, employee representative supervisor, who attended the meeting by means of communication voting). The meeting was presided over by Mr. Zhao Chenxiang, a supervisor jointly elected by more than half of the supervisors. The convening and convening of the meeting shall comply with the relevant provisions of the company law and the articles of association. After full discussion, the attending supervisors deliberated and adopted the following proposals:
1、 The proposal on the work report of the board of supervisors in 2021 was deliberated and adopted.
In accordance with relevant laws, regulations, normative documents, the articles of association and the rules of procedure of the board of supervisors, the board of supervisors of the company prepared the work report of the board of supervisors in 2021.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Materials of 6 Shanghai Raas Blood Products Co.Ltd(002252) 021 annual general meeting of shareholders.
This proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention.
2、 The proposal on the company’s 2021 annual report and summary of annual report was deliberated and passed.
In accordance with the provisions of Article 82 of the securities law and the requirements of the standards for the contents and forms of information disclosure by companies offering securities to the public No. 2 – Contents and forms of annual report, the board of supervisors has comprehensively understood and reviewed the company’s 2021 annual report and put forward the following audit opinions:
(1) The preparation and review procedures of the company’s 2021 annual report comply with the provisions of laws, regulations, the articles of association and the company’s internal management system.
(2) The content and format of the company’s 2021 annual report comply with the provisions of the China Securities Regulatory Commission and the Shanghai Stock Exchange, and the information contained can truly reflect the company’s business management and financial status in 2021 from all aspects.
(3) Before the board of supervisors put forward its opinions, we did not find that the personnel involved in the preparation and deliberation of the 2021 annual report had violated the confidentiality provisions.
This proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention.
3、 The proposal on the company’s financial final accounts report in 2021 was deliberated and adopted.
In accordance with the relevant provisions of the company law and the articles of association, the company has prepared the 2021 final financial statement report after being audited and confirmed by ZTE finance Guanghua Certified Public Accountants (special general partnership).
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Materials of 6 Shanghai Raas Blood Products Co.Ltd(002252) 021 annual general meeting of shareholders.
This proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention.
4、 The plan on profit distribution of the company in 2021 was reviewed and approved.
According to the audit of ZTE caiguanghua Certified Public Accountants (special general partnership), the net profit attributable to the shareholders of the listed company in 2021 was 77842190125 yuan, the net profit deducting non recurring profits and losses attributable to the shareholders of the listed company was -72067381289 yuan, and the net profit of the parent company in 2021 was 16448539334 yuan. The undistributed profit of the parent company at the beginning of 2021 was -595375001835 yuan, and the undistributed profit of the parent company at the end of 2021 was -58045060501 yuan.
According to the relevant provisions of the company law and the articles of association, in view of the negative undistributed profits of the parent company at the end of 2021, the company will not distribute profits or convert the accumulation fund into share capital this year.
This proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention.
5、 The proposal on the company’s 2021 annual internal control evaluation report was deliberated and adopted.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Internal control evaluation report of 6 Shanghai Raas Blood Products Co.Ltd(002252) 021.
Voting results: 5 in favor, 0 against and 0 abstention.
6、 The proposal on Authorizing the company and its holding subsidiaries to apply for loans from related parties in 2022 was deliberated and adopted.
According to the business development needs of the company, it is proposed to authorize the company and its holding subsidiaries to apply for loans from related parties in 2022. For loans with a total amount of no more than 1 billion yuan, a capital cost of no more than 12% and a loan term of no more than 3 years, the management of the company is authorized to handle specific matters according to the actual financing needs within the limit approved by the general meeting of shareholders, This authorization is valid from the effective date of this proposal to the day before the 2022 annual general meeting of shareholders.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Tianjin Songjiang Co.Ltd(600225) on related party transactions of borrowing from related parties in 2022 (Announcement No.: pro 2022033).
This proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention.
7、 The proposal on the planning of shareholders’ dividend return in the next three years (20222024) was deliberated and adopted. For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Dividend return plan for shareholders in Tianjin Songjiang Co.Ltd(600225) next three years (20222024).
This proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention.
8、 The proposal on applying for cancellation of delisting risk warning and other risk warnings of the company’s shares was deliberated and adopted.
After verification, according to the audit report of the company in 2021 issued by ZTE caiguanghua Certified Public Accountants (special general partnership) and the audit report on the elimination of the impact of the matters described in the unqualified opinion with explanatory notes in the audit report in 2020, it shows that the net assets of the company have been regularized at the end of 2021 and the uncertainty of sustainable operation ability has been eliminated. Therefore, the delisting risk warning and other risk warnings of the company’s shares have been eliminated, and the company meets the conditions for applying for cancellation of delisting risk and other risk warnings. The company is approved to apply to Shanghai stock exchange for cancellation of delisting risk warning and other risk warnings of the company’s shares.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Tianjin Songjiang Co.Ltd(600225) on application for cancellation of delisting risk warning and other risk warnings of the company’s shares (Announcement No.: pro 2022034).
Voting results: 5 in favor, 0 against and 0 abstention.
It is hereby announced.
Tianjin Songjiang Co.Ltd(600225) board of supervisors April 27, 2022
